INS and diabetes mellitus: In current clinical practice, genetic etiology of diabetes has been shown to have a big impact on treatment response in the small group of patients who have monogenic diabetes, and for these patients finding the genetic etiology can be life‐changing—transitioning successfully off insulin onto sulfonylurea treatment.